Q2 2020

Source filing unavailable

Q2 2020 · —

Revenue

$30.10M

no prior Q2 2019 on file

Net Income

-$32.05M

no prior Q2 2019 on file

EPS, diluted—

Gross Profit-$4,403,000—

Operating Income-$34,162,000—

Margins · derived

Gross margin-14.6%

Operating margin

Same quarter

no prior Q2 2019 on file

The same fiscal quarter, prior years. Thaler holds no estimates to compare against.

GeneDx Holdings Corp. · CIK 1818331 · Engraved from SEC EDGAR